Strategic Sourcing

Focused Sourcing Drives Business Value

Strategic sourcing guides the evaluation and selection of suppliers which provide innovation, competitive costs and low risks.  At Adventus, we believe that supplier selections and purchasing decisions should always begin with clear intent. Strategic sourcing is about defining value created for the company in terms of quality, delivery, service levels, growth, cost and risk.  Utilizing a category management framework, we help companies understand how the market structure impacts cost drivers, capacity constraints and supplier performance.

Service Description

Category Management and Cost Analysis

Optimize spend across categories using benchmarking and should-cost modeling to drive efficiency and savings.

Strategic Sourcing

Utilize category management sourcing process to achieve business objectives.

Integrated Sourcing and Financial Planning

Align sourcing strategies with financial goals for sustained savings.

Supplier Management

Strengthen supplier relationships to enhance performance and ensure continuity.

Supply Risk Assessment

Identify potential vulnerabilities in the supply chain and implement strategies to mitigate risks proactively.

ESG Supply Management

Incorporate sustainability, ethical sourcing, and governance initiatives to align with corporate responsibility goals and create long-term value.

Why Focused Sourcing

Clarifying quality, delivery, service, financial and other sourcing parameters helps both a company and supplier define value created during the transaction. Teams with budgets to spend can, and often, find suppliers to engage and spend money. Suppliers, knowing who has purchasing authority, will continue to serve their customers directly growing their own business.  Development of category plans and reporting capabilities helps companies properly manage their expenditures, supply risk and growth.

Relevant Client Work

Pharmacovigilance (PV) Services

Reduced costs by 18% for outsourced BPO and technology services through comprehensive sourcing effort for a midsized biopharma company. Collaborated with team members from R&D, PV, IT and Finance to conduct RFI, RFP and finalize executive proposal.

Contract Manufacturing for pharmaceutical materials

Conducted request-for-proposal (RFP) for fill, finish and packaging contract manufacturing organization (CMO) services for pharma client. Working with technical operations, quality and the leadership teams defined issues with current supplier, required attributes, qualification process and timing. Led evaluation process, pricing negotiation and transfer schedule development to meet aggressive budget and timeline.

Corporate Card Services

Corporate card consolidation initiative for newly merged North American operations. Working with treasurer, procurement and executive leadership teams defined use of corporate card payments – physical and virtual – to manage purchases, payment terms and rebates.

Logistics – Freight Audit & Pay Services

Conducted RFP for freight audit and pay services for recently divested North American based industrial manufacturing entity. Led development of RFP, analysis, negotiation, contract management and implementation process. Implemented new service within constraints of Transition Service Agreement (TSA) timeline.

CRO Supplier Management Program

Deployed supplier management process for clinical and pre-clinical studies. Through process identified detail list of cost drivers: project activities, monitoring visit requirements, data management and biostatistics requirements. Working with clinical team and suppliers, reduced project costs through management of service fees, pass through costs and investigator grants.

Relavent Posts & Articles

Essential Medicines And The Need For A Robust U.S. Supply Chain

Essential medicines play a vital role in America’s health, and the supply is closely monitored by the FDA and industry groups. These medicines sustain life, providelife support and/or the prevention of debilitating diseases. The inability to supply these medicines to the market adversely impacts patients and their families’ lives. Currently, there are 227 essential medicines across all dosage forms which face arisk of supply shortage.

Read More »
July 14, 2025

Betting the House: CDMO Selection for Emerging Pharma

Improving the odds of selecting the right CDMO for your organization requires an evaluation of market analysis, manufacturing and quality assessment, financial discussion, and several other key factors. Both the sponsor and the CDMO need to know they can build strong relationships with people to address complex issues while meeting tight deadlines.

Read More »
March 18, 2022